Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
5
Number of overlapping holdings
6.7%
% of HART's 75 holdings also in PJP
20.8%
% of PJP's 24 holdings also in HART
Overlap by Weight
Sector Drift (HART minus PJP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in HART |
Weight in PJP |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 5.0% | 5.9% | 5.0% |
|
JOHNSON & JOHNSON | 4.8% | 5.7% | 4.8% |
|
ABBOTT LABORATORIES | 4.8% | 5.6% | 4.8% |
|
PFIZER INC | 4.7% | 5.5% | 4.7% |
|
UNITED THERAPEUTICS CORP | 0.5% | 3.6% | 0.5% |
Position Highlights (Non-Overlapping Exposures)
HART Overweight Relative to PJP
|
UNITEDHEALTH GROUP INC | 5.3% |
 |
NOVARTIS AG | 5.2% |
 |
ASTRAZENECA PLC | 5.2% |
|
ALPHABET INC. CLASS A | 5.2% |
 |
NOVO NORDISK A/S-B | 5.1% |
|
APPLE INC | 4.9% |
|
BRISTOL-MYERS SQUIBB CO | 4.8% |
 |
SANOFI-AVENTIS | 3.0% |
|
NIKE INC -CL B | 2.9% |
 |
MEDTRONIC PLC | 2.6% |
HART Underweight Relative to PJP
|
AMGEN INC | -6.3% |
|
ABBVIE INC | -6.1% |
|
GILEAD SCIENCES INC | -6.0% |
|
MERCK & CO. INC. | -5.8% |
 |
TARO PHARMACEUTICAL INDUS | -3.7% |
 |
VALEANT PHARMACEUTICALS INT'L | -3.7% |
|
REGENERON PHARMACEUTICALS | -3.6% |
|
BIOGEN IDEC INC | -3.6% |
|
PRESTIGE BRANDS HOLDINGS INC | -3.5% |
|
GERON CORP | -3.4% |